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Abstract 
 
A 52-year-old man was found dead in his bed. He had financial and psychosocial 
problems like separation from his wife and children or unemployment due to alcoholism. 
Under treatment of disulfiram he was presently abstinent from alcohol. As he had 
suffered from epileptic seizures and dizziness, he received valproic acid and the 
vasodilator naftidrofuryl, respectively.  Autopsy showed no morphologic cause of death. 
Chemical analysis of blood revealed concentrations for valproic acid and disulfiram in 
the therapeutic and above the therapeutic range but far below the lethal level, 
respectively. No ethanol was found. However, the very high concentration of 7500 μg/L 
naftidrofuryl in whole blood was considered as cause of death, and the most probable 
manner of death seemed to be suicide. To our knowledge, this is the first reported case of 
a fatal poisoning with naftidrofuryl. 
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1. Introduction 
 
Naftidrofuryl (Fig. 1) blocks the 5-HT2 receptors (type 2 serotonin receptors) and thereby 
inhibits the effects of serotonin-induced vasoconstriction or platelet aggregation. It 
increases the peripheric circulation of blood, e.g. in peripheral vascular disease (PAOD), 
Raynaud's phenomenon,  cerebrovascular diseases, diffuse circulatory insufficiency in the 
elderly going along with confusion or behavioral disturbances [1]. Naftidrofuryl is also a 
stimulator of metabolism by improving aerobic glucose metabolism and by these means 
preserving cell function in ischemic conditions [2]. Overdosage may result in disturbance 
of the atrioventricular conduction time, ventricular arrhythmia [3], convulsions, acute 
renal failure [4] or acute hepatic necrosis [5,6]. 
 
In our case we investigated the body of a deceased man. Chemical screening of urine 
revealed presence of naftidrofuryl; an intoxication with this drug could not be ruled out. 
Therefore the naftidrofuryl amount was determined in peripheral blood and stomach 
contents.  
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2. Case history 
 
2.1 Case history 
 
The decedent was a 52-year-old unemployed man who lived in separation from his wife. 
He was a chronic alcoholic under treatment with disulfiram and had been abstinent for 
the last months. Moreover he had suffered from epileptic seizures but was free from 
convulsions receiving valproic acid. As he complained about dizziness, he was 
additionally treated with naftidrofuryl. One day he was found dead in his bed by his wife. 
Coroner's inquest revealed no injuries except some scratches on the right hand, probably 
caused by the cat living in the same apartment. No loss of urine or feces was noticed. The 
medical examiner estimated that death had occurred about 12 hours before. 
 
2.2 Autopsy findings 
 
External examination of the body (181 cm/ 74,5 kg) in the Institute of Legal Medicine in 
Zurich revealed a tongue wound on its right side. The hands were clenched to fists. In the 
stomach we found 600 ml aequeous content with somewhat digested capsules. We 
determined a total amount of 2.1 grams of naftidrofuryl (calculated as free base, 
corresponding to 13 capsules) in the stomach. The heart was slightly too heavy (440 g; 
according to [7] the normal weight in relation to body length is 300 –380 g) and showed a 
middle to high degree coronary sclerosis. Histological investigation of a plaque in the 
right coronary artery revealed a small accumulation of erythrocytes in the plaque, the 
lumen of the artery however still being widely open. Histology of myocard did not show 
any pathological alterations. The vessels of the body were sclerotic. The lung (2050 g) 
was edematous and the liver (1950 g) showed lymphocytic infiltrations which were 
strictly limited to the portal areas. 
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3. Materials and methods 
 
 3.1 Routine toxicology testing 
 
Routine toxicology testing consisted of blood alcohol analysis by gas chromatography-
flame ionization detection followed by Immunoassays RIA DPC (for free morphine and 
cocaine metabolite in blood) and EMIT d.a.u. (ETS) (for opiates, cocaine metabolite, 
amphetamine/methamphetamine, methadone, barbiturates, and benzodiazepines in urine). 
To urine (10 mL), buffer (acetic acid/sodium acetate, pH 4.5, 10 mL) and beta-
glucuronidase/arylsulfatase (100 µL, Roche Diagnostics) were added. The mixture was 
shaken for 48 hours at 37 °C to achieve enzymatic hydrolysis of conjugated compounds. 
The mixture was set to pH 2 with tartaric acid, then extracted five times with t-butyl-
methyl-ether (totally 170 mL). The combined extracts containing the acidic-neutral 
fraction of urine were evaporated to dryness, then reconstituted with methanol (500 µL) 
for HPTLC. The aqueous fraction was adjusted to pH 8.8–9.0 by adding ammonia (10 
%)/ammonium chloride (saturated solution), then extracted 4 times with 
dichloromethane/methanol (20:1 v/v, totally 140 mL). The combined extracts containing 
the basic-amphoteric fraction of urine were evaporated to dryness and then reconstituted 
with methanol (100 µL) for HPTLC and GC-MS.  
 
Two dimensional HPTLC screenings of the acidic-neutral and the basic-amphoteric 
fraction were done according to [8] and [9], respectively. UV/VIS remission of spots 
were taken with a CAMAG TLC scanner 3. 
 
Further qualitative screening of a part of the basic-amphoteric fraction corresponding to 
0.1 mL of urine was done on a Varian Saturn 4D GC-MS System (full-scan EI mode, 
scan range m/z 41–500, helium as carrier gas, flow rate 1.5 mL/min, column J&W DB-
5ms, 30 m x 0.25 mm i.d. with 0.25 μm film, programmed from 120 °C to 280  °C at 20 
°C/min, initial hold time 2 min). 
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3.2 Quantitation of naftidrofuryl in blood 
 
An Isolute HCX 300 mg solid-phase extraction (SPE) column was conditioned with 
methanol (2 mL) and phosphate buffer (pH=6, 2 mL) under vacuum at a flow rate of 2 
mL/min. Periperic blood (2 mL) was diluted with phosphate buffer (pH=6, 12 mL) and 
applied to the column. The flow rate was reduced to 1.5 mL/min. After washing with 
water (1 mL) and 0.01 M acetic acid (0.5 mL), the column was dried for 4 min under 
vacuum. 50 µL of methanol were applied to the column and again the column was dried 
as before for 1 min. The column was centrifuged to completly remove solvents. Further 
washing was done with acetone/chloroform (1:1 v/v, 4 mL). The fraction eluted with 
dichloro-methane/isopropanol/ammonium hydroxide (8:2:0.5 v/v, 2 mL) was collected, 
evaporated to dryness and then reconstituted with 50 µl of methanol. Quantitation was 
done with 1 µL of the reconstituted extract on a Carlo Erba GC equipped with a CTC 
A200S Autosampler, a DB-1 column (15 m x 0.53 mm i.d. with 1.5 µm film), and a 
flameless nitrogen-phosphorus detector (NPD, splitless injection, injector: 280 °C; 
column: 2 min isothermic at 170 °C, then programmed from 170 °C to 220 °C at 5 
°C/min and from 220 °C to 270 °C at 25 °C/min, final hold time 4 min; detector: 300 °C). 
Retention time for naftidrofuryl was 13.1 min. Methadone (retention time 4.9 min) was 
used as an internal standard for general performance control at a concentration of 100 
ng/mL blood.  Calibration was done with methanolic solutions of naftidrofuryl oxalate 
(Lipha) at concentrations corresponding to 12.5 ng/µL and 314 ng/µL free naftidrofuryl 
base. A forced zero two point calibration curve (R2=1) was obtained from three injections 
(1 µL) of each calibrator level. The upper calibrator level was chosen to give a peak area 
approximately corresponding to that of the extract of the autopsy blood. Recovery was 90 
percent as determined from a spiked negative testing blood sample (2 mL) with 314 
ng/mL naftidrofuryl (calculated as free base), extracted in the same manner as described 
above for autopsy blood.  The method LOD [10] was 30 μg/L blood and LLOQ was 75 
μg/L blood. ULOL was not determined as the naftidrofuryl concentration in the autopsy 
peripheric blood was within the linear range. Accuracy (bias) was within ± 15 % of 
nominal value, precision within 15 % R.S.D. 
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Only a limited volume of peripheric blood was available from autopsy. Therefore, we 
used heart blood for the quantitation of disulfiram, mefenamic acid and valproic acid.  
 
3.3 Quantitation of disulfiram in blood 
 
Disulfiram and its metabolites were cleaved to carbon disulfide by addition of phosphoric 
acid (20 %, 1 mL) to a headspace vial containing heart blood (1 mL) and distilled water 
(1 mL) and heated (80 °C, 60 min). For calibration, samples of heart blood tested 
negative for disulfiram were spiked with known amounts of disulfiram (1000 µg/L, 500 
µg/L and 100 µg/L) and treated by the same way. Carbon disulfide was measured by 
headspace GC-MS (Varian Saturn 4D, fullscan mode, scan range m/z 40–200, helium as 
carrier gas, flow rate 1.8 mL/min, column GS-Q (J&W Scientific), 30 m, 0.32 µm i.d., 
starting temperature 60 °C, held isothermic for 2 min., heating rate 20 °C/min, final 
temperature 200 °C, held for 10 min) comparing the peak areas of mass m/z 76 of the 
case samples and the calibration samples. The result was calculated as disulfiram 
equivalents. As 1 mole of disulfiram produces 2 moles of carbon disulfide, 1 µg of 
disulfiram (molecular mass 296.5) corresponds to 0.51 µg of carbon disulfide (molecular 
mass 76.1). An analogous procedure, but with water (1 mL) instead of phosphoric acid 
was used to determine the content of free carbon disulfide in heart blood (calculated as 
disulfiram equivalents). Negative controls for total carbon disulfide were done with blood 
samples tested negative for disulfiram, distilled water and phosphoric acid as described 
above, for the negative controls of free carbon disulfide no phosphoric acid was added. 
 
3.4 Quantitation of mefenamic acid in blood 
 
Heart blood (2 mL) was treated by ultrasound for 10 min. Proteins were precipitated by 
addition of hydrochloric acid (0.1 N, 12 mL) and vortex mixing followed by 
centrifugation at 3000 rpm for 10 min. The supernatant was transferred to an Isolute 
HCX SPE column (300 mg/10 ml), pretreated with methanol (2.5 mL) and hydrochloric 
acid (0.1 N, 2.5 mL). The column was washed with hydrochloric acid (0.1 N, 4 mL) and 
hexane (3 ml). The column was then dried under vacuum for 5 min. Mefenamic acid was 
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eluted with t-butyl-methyl-ether. The extract was evaporated to dryness under nitrogen. 
The sample was reconstituted in 50 µL of methanol and analyzed by HPLC on a Dionex 
LC system with diode array detection (DAD) on a Waters Spherisorb OD/CN column (5 
µm, 150 x 4.6 mm) with 10 µL of the sample at a detection wavelength of 230 nm. 
Retention time for mefenamic acid was 10.7 min. For calibration, standards of 
mefenamic acid (41.0 ng/µL and 66.7 ng/µL) were used. 
 
3.5 Quantitation of valproic acid in blood 
 
Three samples of heart blood (1 mL each) were analyzed as follows: chloroform (0.5 mL) 
followed by hydrochloric acid (3 M, 1 mL) was added under vortex mixing. After 
centrifugation (3000 rpm, 15 min), the chloroform phase was separated from the mixture.  
 
Three samples of blood tested negative for valproic acid (1 mL each) were spiked with 99 
µg of valproic acid and were used as calibrators and treated as described above for the 
heart blood samples. As negative control, an unspiked blood sample (1 mL) was treated 
the same way. 
 
All chloroform extracts were analyzed by GC-MS (Varian Saturn 4D, fullscan mode, 
scan range m/z 41–249, helium as carrier gas, flow rate 1.5 mL/min, column DB-5ms, 30 
m,  0.25 µm i.d., starting temperature 100 °C, held isothermic for 2 min., heating rate 20 
°C/min, final temperature 280 °C, held for 20 min). Valproic acid had a retention time of 
5.00 min and was identified by its mass spectrum. For quantitation, the peak area of mass 
m/z 73 (base peak) was determined. Valproic acid content was then calculated from the 
mean peak area value of the three heart blood samples where the mean peak area value of 
the three calibrator samples corresponded to 99 µg. No signal for valproic acid was 
detected in the negative control. 
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3.6 Quantitation of naftidrofuryl and mefenamic acid in stomach contents 
 
At the autopsy, a total of 600 mL stomach contents was collected. A pH of 4.0 was 
observed. The stomach contents consisted of a supernatant yellowish liquid over a layer 
of beige mud, covering a layer of small microgranules with pink colour. 
 
An Isolute HCX 300 mg solid phase extraction column was conditioned as described 
above for the quantitation of  naftidrofuryl. 3 mL of the homogenized stomach contents 
were diluted with phosphate buffer (pH=6, 18 mL) and applied to the column. The flow 
rate was reduced to 1.5 mL/min. After washing with water (1 mL) and 0.01 M acetic acid 
(0.5 mL), the column was dried for 4 min under vacuum. 50 µL of methanol were applied 
to the column and again the column was dried as before for 1 min. The column was 
centrifuged to completly remove solvents. With acetone/chloroform (1:1 v/v, 4 mL), the 
fraction  of neutral and acidic compounds (Fraction 1) was eluted, collected, and taken to 
dryness. Finally, the fraction of basic and amphoteric compounds (Fraction 2) was eluted 
from the column with dichloro-methane/isopropanol/ammonium hydroxide (8:2:0.5 v/v, 
2 mL) and taken to dryness.  
 
Fraction 1 was dissolved in 150 µL of methanol (solution 1). For quantitation of 
mefenamic acid, 20 µL of solution 1 were diluted with 100 µL of methanol. Samples of 1 
and 2 µL of the dilution were applied to TLC plates silica gel F254 (20 x 10 cm, Merck, 
Darmstadt/Germany), alternating with calibrators of 100, 200, 400, 600, and 800 ng 
mefenamic acid. The plate was developed in a mixture of toluene, t-butyl-methyl-ether, 
glacial acetic acid, and methanol (60:30:9:1 v/v/v/v). Identification and quantitation of 
mefenamic acid were done with a CAMAG TLC scanner 3. Mefenamic acid was detected 
at an Rf-value of 0.74 by its UV remission spectrum. Quantitation was done at a 
wavelength of 350 nm (polynomial regression, r = 0.99757 via height and r = 0.99778 via 
area).  
 
By qualitative HPTLC with identification of the compounds by their UV remission 
spectra it was found that naftidrofuryl was detectable as well in fraction 1 as in fraction 2. 
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The total naftidrofuryl content of the stomach contents had therefore to be determined as 
sum of the quantitations in the two fractions. These quantitations were done in a similar 
way to that described for mefenamic acid, but with development of the TLC plates in a 
mixture of methanol and ammonia (99:1 v/v). Naftidrofuryl was identified by its UV 
remission spectrum at an Rf-value of 0.52–0.58. Quantitation was done at a wavelength 
of 283 nm. 
 
Fraction 1: 10 µL of solution 1 (see above) were diluted with 1190 µL of methanol. 0.5 
and 1 µL of the dilution were applied to a TLC plate as described above, alternating with 
naftidrofuryl calibrators of 100, 200, 400, 600, and 800 ng. Polynomial regression curve: 
r = 0.99318 via height, r = 0.99866 via area. Fraction 2: 10 µL of a solution of fraction 2 
in 150 µL of methanol were diluted with 590 µL of methanol. 0.5 and 1 µL of the 
dilution were applied to a TLC plate, calibrators were as described for fraction 1. 
Polynomial regression curve: r = 0.99934 via height, r = 0.99942 via area. 
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4. Results from drug analysis 
 
No alcohol was detected in the blood and all immunoassays for routine toxicology testing 
were negative. The chemical screening of the acidic-neutral and of the basic-amphoteric 
urine fraction revealed the presence of naftidrofuryl, its desethyl metabolite, mefenamic 
acid and two of its metabolites, and of valproic acid. We also found caffeine, 
theobromine, nicotine, cotinine and hydroxycotinine in urine which were considered to 
be of no toxicological relevance. The results of quantitative determination of 
naftidrofuryl, disulfiram, valproic acid and mefenamic acid are listed in Table 1. Mass 
spectrum and GC-NPD chromatogram of naftidrofuryl are shown in Figure 2 and 3 (a-d), 
respectively. Naftidrofuryl concentration in peripheral blood was found to be 7500 μg/L, 
which is 15 times higher than the higher level of the therapeutic range of 500 μg/L 
plasma [5]. Disulfiram was measured in heart blood as disulfiram equivalents. This 
concentration (900 μg/L) was above the therapeutic range of 50 to 400 μg/L serum, but 
far below the lethal level of 8 mg/L. The concentration of valproic acid and of mefenamic 
acid in heart blood was 50 mg/L and 6.8 mg/L, respectively, in accordance with  
therapeutic levels. In stomach contents we found 2.36 mg naftidrofuryl per mL in the 
fraction of neutral and acidic compounds (fraction 1) and 1.16 mg per mL in the fraction 
of basic and amphoteric compounds (fraction 2). 
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5. Discussion 
  
The autopsy of the body of the 52-year-old man did not reveal a morphologically visible 
cause of death. The heart was slightly too heavy which does not explain death. We 
observed a coronary sclerosis and in a plaque of the right coronary vessel we found a 
fresh assembly of erythrocytes. However the lumen was still wide and there was no 
relevant obstruction for blood flow. Histological examination of myocard was namely 
inconspicuous and did not show any fresh ischemic lesions. We therefore excluded a 
coronary heart death. The liver showed a chronic inflammation of the portal areas which 
we attributed to chronic alcohol consumption.  
 
Analysis of blood showed the presence of naftidrofuryl, disulfiram, valproic acid and 
mefenamic acid. Disulfiram inhibits selectively the action of acetaldehyde dehydrogenase 
in the liver [1]. When taken together with alcohol, the concentration of acetaldehyde in 
blood increases, which can lead to flushes, headache, nausea, dizziness, tachycardia, 
hypotension or even collapse. The symptoms develop 5 to 10 minutes after intake of 
alcohol and can last several hours. This unpleasant reaction prevents patients under 
disulfiram treatment from consuming alcohol. Disulfiram is delivered as dispersible 
tablets containing 400 mg disulfiram. Normal dosage for maintenance therapy is half a 
tablet every day or one tablet every second day. 90% percent of an oral dose of the highly 
lipid soluble disulfiram is absorbed and completely reduced within 4 minutes to 
diethyldithiocarbamate, which is thought to be the pharmacologically active principle. It 
is further metabolized to methyldiethyldithiocarbamate, carbon disulfide and 
diethylamine. Their concentrations and their elimination half-life vary highly from 
subject to subject [11].  
 
Valproic acid is a well-known antiepileptic agent, used especially to treat generalized 
seizures [1]. The dosage depends on weight and age. The therapeutic concentration in 
plasma is 40-150 mg/L [12]. Massive overdosage results in coma and can lead to death, 
however prognosis of overdosage is good.  
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Mefenamic acid is a non-steroidal analgetic. Not more than 2 g per day of mefenamic 
acid should be taken. A serum level of 2 to 20 mg/L is considered to be therapeutic [12]. 
Overdosage leads to seizures and myoclonus.  
 
Our toxicological investigation revealed a very high concentration of naftidrofuryl in 
blood as the only relevant finding. The blood levels of the other substances i.e. 
disulfiram, valproic acid and mefenamic acid were far below lethal concentrations and 
none of these substances is known to show any interaction with naftidrofuryl.  
 
Naftidrofuryl is available as capsules in Switzerland; together with the facts that such a 
capsule contains 200 mg naftidrofuryl oxalate (corresponds to 162 mg free base), that 
three capsules a day are a usual therapeutic dose [1], that a single oral administration of 
200 mg naftidrofuryl oxalate results in a peak plasma concentration of approximately 275 
μg/L [13], and that plasma levels up to 500 μg/L are considered as therapeutic [12], the 
very high concentration of 7500 μg/L naftidrofuryl in blood in our case is to consider as 
toxic. Taking further into account the not yet resorbed toxic potential of 2.1 g 
naftidrofuryl found in the stomach contents, we conclude that a naftidrofuryl overdose 
must be the cause of death. To the best of our knowledge this is the first report of a fatal 
naftidrofuryl poisoning.  
  
Naftidrofuryl is known to cause cardial conduction problems and convulsions when taken 
in higher amounts. As sign of convulsions we found a bite in the tongue. It seems that the 
decedent suffered from terminal seizures although he was under treatment with valproic 
acid and although its blood level was in the therapeutic range. Apparently, the valproic 
acid level was not high enough to prevent naftidrofuryl-induced seizures.  
 
The police closed the case assuming suicide since it is unlikely that the high 
concentration of naftidrofuryl in the blood and in the stomach contents results from an 
accidental intake of such a huge amount of naftidrofuryl. The motive for the suicide may 
have layed in a difficult psychosocial situation of the man.  
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Table 
 
Table 1: Drug concentrations in blood and stomach contents 
 
 Concentrations 
 Peripheral blood 
(mg/L) 
Heart blood  
(mg/L) 
Stomach Contents 
(mg/L) 
Ethanol 0.0 n.m. n.m. 
Naftidrofuryl 7.5 n.m. 3500 
Valproic acid n.m. 50 n.m. 
Mefenamic acid n.m. 6.8 100 
Total carbon disulfidea n.m. 0.9 n.m. 
Free carbon disulfidea n.m. 0.14 n.m. 
 
n.m. – not measured 
a calculated as disulfiram equivalents 
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Figures 
 
Fig. 1. Structure of naftidrofuryl.  
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Fig. 2. Mass spectrum of naftidrofuryl (M = 383; m/z 384 (M+1)+). 
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Fig. 3. Chromatograms (GC-NPD). 
 
a. Extract of peripheric blood from autopsy (2 mL), injected 1/50 (1 µL). Naftidrofuryl: tR 
= 13.098 min, methadone (IS): tR = 4.947 min. 
 
 
 
 
 19
b. Calibrator mixture (3.8 ng methadone and 12.5 ng naftidrofuryl). 
 
 
 
 
 
 
 
 
c. Extract (injected 1/50 (1 µL methanolic solution)) of a blood sample (2 mL), tested 
negative for methadone and naftidrofuryl, spiked with 95 ng methadone and 314 ng 
naftidrofuryl. 
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d. Extract (injected 1/50 (1 µL)) of a blood sample (2 mL), tested negative for methadone 
and naftidrofuryl, spiked with 95 ng methadone only (negative control for naftidrofuryl). 
 
 
 
 
 
